Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors

Title:	A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors
Authors:	Liu, Dan^Aff1; Gong, Jifang^Aff1; Zhang, Jian^Aff2; Shu, Yongqian^Aff3; Wu, Hao^Aff3; Liu, Tianshu^Aff4; Xu, Yanhua^Aff5; Zhang, Lijia^Aff5; Li, Min^Aff5; Hu, Xichun^{Aff2, Aff6, IDs1063702501512z_cor1}; Shen, Lin^{Aff7, Aff8, IDs1063702501512z_cor2}
Source:	Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 43(2):250-261
Database:	Springer Nature Journals